We were able to demonstrate significantly different IL-17 production in response to Rv1886c (Ag85B) in individuals from group 2 (non TB, other respiratory disease) and 3 (health care workers, exposed to TB) as compared to individuals in group 1 (pulmonary TB). This evidence concerns the gene IL17A and respiratory system disorder.